APLI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Appili Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.005 CAD -50% Market Closed

Market Cap: CA$661.9k

	Appili Therapeutics Inc TSX:APLI	CA
S	Sirona Biochem Corp SWB:ZSB	CA
M	Mitsui & Co Ltd XMUN:MTS1	JP
I	Industria de Diseno Textil SA WSE:ITX	ES
	Proto Labs Inc LSE:0KRR	US

Profitability Summary

Appili Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 666%

Negative 3Y Average Operating Margin

-2 643%

Declining Operating Margin

-1 248% > -1 666%

Negative Net Margin

-1 294%

Negative 3Y Average Net Margin

-1 329%

Declining Net Margin

-1 166% > -1 294%

Negative Free Cash Flow Margin

-378%

Negative 3Y Average Free Cash Flow Margin

-127%

Free Cash Flow Margin is Increasing

-651% > -378%

Exceptional ROE

28%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

274%

Declining ROIC

842% > 135%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.